EORTC Quality of Life group selected abstracts at ISOQOL 2020
15 Oct 2020
The 27th Annual Conference ISOQOL will take place virtually from 19 to 23 October 2020.
The EORTC have been lucky to have 12 abstracts accepted for the International Society of Quality of Life Annual Conference. This conference is one of the primer venues to have high quality research presented, and so we are very happy that the EORTC have had such a good success in 2020. Dr. Andrew Bottomley, Assistant Director and Head of the Quality of life Department says “it’s great that the EORCT has such a good publication record, and impressive to see the broad nature of the work that is being done across the EORTC”
(Please note that they are all on-demand sessions)
Symposiums
Symposium 2: Do you know what I mean? Interpreting PRO/HRQOL scores at group and individual level.
Date: 12:00 AM–11:00 PM Oct 24, 2020 (US – Central) / 7AM Oct 24 – 6AM Oct 25, 2020 CET
Moderator: Corneel Coens, EORTC HQ, Brussels, Belgium
Discussants:
- Galina Velikova, PhD MD, Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds Cancer Centre, Leeds, United Kingdom
- Madeleine King, PhD, University of Sydney, Sydney, Australia; Submitted on behalf of EORTC Quality of Life Group
Individual Presentations:
Interpretation of patient reported outcome data at group-level versus individual-level; can we use the same clinical meaningful thresholds for both scenarios?
Jammbe Musoro, PhD, EORTC HQ, Brussels, Belgium
Development and use of thresholds for clinical importance to facilitate interpretation of scores from patient-reported outcome measures
Johannes Giesinger, PhD, Medical University of Innsbruck, Innsbruck, Austria
Norm data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons from the European general population, Canada, and the USA.
Sandra Nolte, PhD, ICON plc, Berlin, Germany
Symposium 9: Using the estimand framework to align study design and analysis with patient-reported outcome objectives: the times they are a-changin’
Date: 12:00 AM–11:00 PM Oct 24, 2020 (US – Central) / 7AM Oct 24 – 6AM Oct 25, 2020 CET
Moderators:
- Bellinda King-Kallimanis, PhD, U.S. Food and Drug Administration, Silver Spring, Maryland, United States
- Madeline Pe, PhD, EORTC Quality of Life Department, Brussels, Belgium
Individual Presentations:
An HTA perspective on the treatment policy estimand if the endpoint is repeatedly measured over time
Christoph Schürmann, Dr., IQWiG – Institute for Quality and Efficiency in Health Care, Cologne, Germany
Why & how to use time-to-event endpoints for COAs & how can the estimand framework help?
Rachael Lawrance, Adelphi Values Ltd, Bollington, United Kingdom
Applying the Estimand Framework to Describe Patient Experience While on Treatment: A Case Study
Mallorie Fiero, PhD, U.S. Food and Drug Administration, Silver Spring, Maryland, United States
Oral sessions
Use of the Common Terminology Criteria for Adverse Events (CTCAE) framework to summarize symptomatic toxicities in the European Organisation for Research and Treatment of Cancer (EORTC) Item Library
Date: 12:03 AM–11:00 PM Oct 24, 2020 (US – Central) / 7.03AM Oct 24 – 6AM Oct 25, 2020 CET
Session Details: Oral Brief Session 202: Methods I
Authors: Claire Piccinin, Andrew Bottomley, Mogens Groenvold, Dagmara Kuliś, Galina Velikova, & Alexandra Gilbert
Validation of a positive affect item bank – a supplement to the EORTC CAT Core
Date: 12:02 AM–11:00 PM Oct 24, 2020 (US – Central) / 7.02AM Oct 24 – 6AM Oct 25, 2020 CET
Session Details: Oral Session 105: Efficiency and quality in the development and application of PROs
Authors: Morten Aa. Petersen, Eva-Maria Gamper, Anna Costantini, Johannes M. Giesinger, Bernhard Holzner, Colin Johnson, Monika Sztankay, Teresa Young & Mogens Groenvold
Poster sessions
From item to interface: updating the EORTC Item Library using results from a qualitative content analysis
Date: 12:04 AM–11:00 PMOct 24, 2020 (US – Central) / 7.04AM Oct 24 – 6AM Oct 25, 2020 CET
Session Details: Poster Session: Qualitative & Mixed Methods Research I Presentation Number: 3174
Authors: Claire Piccinin, Dagmara Kuliś, Andrew Bottomley, Francesca Martinelli, Madeline Pe, & Mogens Groenvold
Evaluating the readability of the EORTC Quality of Life Questionnaire QLQ-C30
Date: 12:04 AM–11:00 PM Oct 24, 2020 (US – Central) / 7.04AM Oct 24 – 6AM Oct 25, 2020 CET
Session Details: Poster Session: Qualitative & Mixed Methods Research II Presentation Number: 3193
Authors: Dagmara Kuliś, Anne Stone, Anne-Sophie Darlington, Andrew Bottomley
Clustering of EORTC QLQ-C30 health-related quality of life scales across several disease sites
Date: 12:04 AM–11:00 PM Oct 24, 2020 (US – Central) / 7.04AM Oct 24 – 6AM Oct 25, 2020 CET
Poster Session: Psychometrics & Statistics Presentation Number: 3168
Authors: Abigirl Machingura, EORTC – Co-Authors: Jammbe Musoro, Jolie Ringash, Mekdes Taye, Madeline Pe, Corneel Coens, Francesca Martinelli, Dongsheng Tu, Ethan Basch, Yvonne Brandberg, Mogens Grønvold, Alexander Eggermont, Fatima Cardoso, Jan Van Meerbeeck, Winette Van der Graaf, Martin Taphoorn, Jaap Reijnveld, Riccardo Soffietti, Galina Velikova, Henning Flechtner, Andrew Bottomley
Satisfaction with communication in cancer patients: the role of patient evaluation of their competence in communicating with healthcare professionals. An international EORTC study
Date: 12:04 AM–11:00 PM Oct 24, 2020 (US – Central) / 7.04AM Oct 24 – 6AM Oct 25, 2020 CET
Poster Session: Cancer Research in Older & Vulnerable Populations Presentation Number: 3054
Authors: Juan Ignacio Arraras, Johannes Giesinger, Omar Shamieh, Iqbal Bahar, Eva Greimel
Quality of Life in cancer patients: the role of the patients’ evaluation of the information
Date: 12:04 AM–11:00 PM Oct 24, 2020 (US – Central) / 7.04AM Oct 24 – 6AM Oct 25, 2020 CET
Poster Session: Poster Session: Methodological Considerations in Cancer Research Presentation Number: 3135
Authors: Johannes M. Giesinger. Juan Ignacio Arraras, Iqbal Bahar, Eva Greimel, Omar, Meropi Kontogianni. Maja Wolan, Yuichiro Kikawa, Dagmara Kulis
Development of an E-Learning Course on EORTC Patient-Reported Outcome Measures in Clinical Practice: Rationale and study design of Phase I content generation
Date: 12:04 AM–11:00 PM Oct 24, 2020 (US – Central) / 7.04AM Oct 24 – 6AM Oct 25, 2020 CET
Poster Session: Cancer Clinical Care Presentation Number: 3019
Authors: Schmidt Heike, Wintner L.M., Roggendorf S., Nordhausen T., Dirven L., Taphoorn M.J., Verdonck- de Leeuw I.M., Velikova G., Bottomley A., Kulis D, Sztankay M
Creating User-Relevant Content for an E-Learning Course on EORTC Patient-Reported Outcome Measures in Clinical Practice: Results of the Qualitative Analyses of Stakeholder Perspectives
Date: 12:04 AM–11:00 PM Oct 24, 2020 (US – Central) / 7.04AM Oct 24 – 6AM Oct 25, 2020 CET
Poster Session: Cancer Clinical Care – Presentation Number: 3030
Authors: Sztankay M.,Wintner L.M., Roggendorf S., Nordhausen T., Dirven L., Taphoorn M.J.B., Verdonck- de Leeuw I.M., Velikova G., Bottomley A. Kulis D, Schmidt H.
More information on ISOQOL 2020 website.
Related News
EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023